Department of Pediatrics, Stanford University, Stanford, CA, USA.
ReGen Med Division, BOCO Silicon Valley, Palo Alto, CA, USA.
Nat Methods. 2018 Dec;15(12):1045-1047. doi: 10.1038/s41592-018-0212-y. Epub 2018 Nov 30.
Scarless genome editing in human pluripotent stem cells (hPSCs) represents a goal for both precise research applications and clinical translation of hPSC-derived therapies. Here we established a versatile and efficient method that combines CRISPR-Cas9-mediated homologous recombination with positive-negative selection of edited clones to generate scarless genetic changes in hPSCs.
无痕基因组编辑在人类多能干细胞(hPSCs)中代表了一个精确研究应用和 hPSC 衍生疗法临床转化的目标。在这里,我们建立了一种通用且高效的方法,该方法将 CRISPR-Cas9 介导的同源重组与编辑克隆的正负选择相结合,在 hPSCs 中产生无痕的遗传变化。